Screener
Mesa Laboratories MLAB Business Segments
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Biopharmaceutical Development | $12.06M+5.0% | $8.85M-29.9% | $14.37M+17.5% | $13.92M+17.3% | $11.49M-4.3% | |
| Calibration Solutions | $13.29M+7.6% | —— | $14.07M-2.5% | $13.57M+10.7% | $12.35M+4.7% | |
| Clinical Genomics | $10.29M-0.1% | $12.18M+5.8% | $11.77M-7.1% | $11.14M-3.1% | $10.3M-9.7% | |
| Sterilization And Disinfection Control | $24.51M-3.6% | $29.14M+17.7% | $24.91M+6.0% | $22.11M-0.4% | $25.41M+10.7% | |
| Revenue by Product | ||||||
| Consumables | $34.78M-2.8% | —— | $36.73M-0.2% | $33.38M+4.6% | $35.77M+8.4% | |
| Hardware And Software | $14.13M+12.4% | —— | $17.34M+9.8% | $16.07M+2.9% | $12.57M-10.7% | |
| Service | $11.24M+0.3% | $12.2M+11.3% | $11.05M+8.0% | $11.29M+9.6% | $11.2M+1.0% | |
| Revenue by Geography | ||||||
| CN | $5.44M+0.1% | $4.06M-19.5% | $5.65M-10.7% | $5.32M-28.1% | $5.43M-17.2% | |
| Other | $24.96M-5.7% | $29.61M+14.3% | $29.59M+13.6% | $26.12M+16.8% | $26.47M+6.9% | |
| US | $29.74M+7.6% | $30.06M-3.7% | $29.89M-1.9% | $29.3M+4.4% | $27.65M+2.9% |
FAQ
- How does Mesa Laboratories break its business down?
- Mesa Laboratories (MLAB) reports revenue by business across 4 parts — Biopharmaceutical Development, Calibration Solutions, Clinical Genomics and Sterilization And Disinfection Control. Each is extracted from the segment footnotes and tracked over time.
- Where does Mesa Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Mesa Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
